The Synergistic Effect of Ginkgo biloba Extract 50 and Aspirin Against Platelet Aggregation

References

• McFadyenJD, SchaffM, PeterK. Current and future antiplatelet therapies: emphasis on preserving haemostasis. Nat Rev Cardiol. 2018;15(3):181–191. doi:10.1038/nrcardio.2017.20629297508
   PubMed Web of Science ®Google Scholar
• RengasamyKRR, KhanH, AhmadI, et al. Bioactive peptides and proteins as alternative antiplatelet drugs. Med Res Rev. 2019;39(6):2153–2171. doi:10.1002/med.2157931006878
   PubMed Web of Science ®Google Scholar
• BenjaminEJ, ViraniSS, CallawayCW, et al. Heart disease and stroke statistics-2018 update: a report from the American heart association. Circulation. 2018;137(12):e67–e492.29386200
   PubMed Web of Science ®Google Scholar
• EstevezB, DuX. New concepts and mechanisms of platelet activation signaling. Physiology (Bethesda). 2017;32(2):162–177.28228483
   PubMed Web of Science ®Google Scholar
• XiangQ, PangX, LiuZ, et al. Progress in the development of antiplatelet agents: focus on the targeted molecular pathway from bench to clinic. Pharmacol Ther. 2019;203:107393. doi:10.1016/j.pharmthera.2019.10739331356909
   PubMed Web of Science ®Google Scholar
• van der MeijdenPEJ, HeemskerkJWM. Platelet biology and functions: new concepts and clinical perspectives. Nat Rev Cardiol. 2019;16(3):166–179. doi:10.1038/s41569-018-0110-030429532
   PubMed Web of Science ®Google Scholar
• YeungJ, LiW, HolinstatM. Platelet signaling and disease: targeted therapy for thrombosis and other related diseases. Pharmacol Rev. 2018;70(3):526–548. doi:10.1124/pr.117.01453029925522
   PubMed Web of Science ®Google Scholar
• LordanR, TsouprasA, ZabetakisI. Platelet activation and prothrombotic mediators at the nexus of inflammation and atherosclerosis: potential role of antiplatelet agents. Blood Rev. 2020;45:100694.32340775
   PubMed Web of Science ®Google Scholar
• KnowlesRB, WarnerTD. Anti-platelet drugs and their necessary interaction with endothelial mediators and platelet cyclic nucleotides for therapeutic efficacy. Pharmacol Ther. 2019;193:83–90. doi:10.1016/j.pharmthera.2018.08.00430081048
   PubMed Web of Science ®Google Scholar
• ZengY, LiuJ, ZhangQ, et al. The traditional uses, phytochemistry and pharmacology of Sarcandra glabra (Thunb.) nakai, a Chinese herb with potential for development: review. Front Pharmacol. 2021;12:652926. doi:10.3389/fphar.2021.65292633967794
   PubMed Web of Science ®Google Scholar
• LiXJ, TangSQ, HuangH, et al. Acanthopanax henryi: review of botany, phytochemistry and pharmacology. Molecules. 2021;26(8):2215.33921386
   PubMed Web of Science ®Google Scholar
• ChenM, DingY, TongZ. Efficacy and safety of Sophora flavescens (Kushen) based traditional Chinese medicine in the treatment of ulcerative colitis: clinical evidence and potential mechanisms. Front Pharmacol. 2020;11:603476. doi:10.3389/fphar.2020.60347633362558
   PubMed Web of Science ®Google Scholar
• DaiYJ, WanSY, GongSS, LiuJC, LiF, KouJP. Recent advances of traditional Chinese medicine on the prevention and treatment of COVID-19. Chin J Nat Med. 2020;18(12):881–889.33357718
   PubMed Web of Science ®Google Scholar
• ZhangL, YuJ, ZhouY, ShenM, SunL. Becoming a faithful defender: traditional Chinese medicine against coronavirus disease 2019 (COVID-19). Am J Chin Med. 2020;48(4):763–777. doi:10.1142/S0192415X2050038X32349517
   PubMed Web of Science ®Google Scholar
• KumarA, JaitakV. Natural products as multidrug resistance modulators in cancer. Eur J Med Chem. 2019;176:268–291. doi:10.1016/j.ejmech.2019.05.02731103904
   PubMed Web of Science ®Google Scholar
• FusterV, SweenyJM. Aspirin: a historical and contemporary therapeutic overview. Circulation. 2011;123(7):768–778. doi:10.1161/CIRCULATIONAHA.110.96384321343593
   PubMed Web of Science ®Google Scholar
• LiuL, WangY, ZhangJ, WangS. Advances in the chemical constituents and chemical analysis of Ginkgo biloba leaf, extract, and phytopharmaceuticals. J Pharm Biomed Anal. 2021;193:113704. doi:10.1016/j.jpba.2020.11370433157480
   PubMed Web of Science ®Google Scholar
• LordanR, TsouprasA, ZabetakisI, DemopoulosCA. Forty years since the structural elucidation of platelet-activating factor (PAF): historical, current, and future research perspectives. Molecules. 2019;24(23):4414. doi:10.3390/molecules24234414
   Web of Science ®Google Scholar
• HylandIK, O’TooleRF, SmithJA, BissemberAC. Progress in the development of platelet-activating factor receptor (PAFr) antagonists and applications in the treatment of inflammatory diseases. ChemMedChem. 2018;13(18):1873–1884. doi:10.1002/cmdc.20180040130009544
   PubMed Web of Science ®Google Scholar
• KoltaiM, HosfordD, GuinotP, EsanuA, BraquetP. Platelet activating factor (PAF). A review of its effects, antagonists and possible future clinical implications (Part I). Drugs. 1991;42(1):9–29. doi:10.2165/00003495-199142010-000021718687
   PubMed Web of Science ®Google Scholar
• ConstantinosA, KarantonisHC, AntonopoulouS. Platelet activating factor — a molecular link between atherosclerosis theories. Eur J Lipid Sci Technol. 2003;105(11):705–716. doi:10.1002/ejlt.200300845
   Web of Science ®Google Scholar
• Achete de SouzaG, de MarquiSV, MatiasJN, GuiguerEL, BarbalhoSM. Effects of Ginkgo biloba on diseases related to oxidative stress. Planta Med. 2020;86(6):376–386. doi:10.1055/a-1109-340532097975
   PubMed Web of Science ®Google Scholar
• SinghSK, SrivastavS, CastellaniRJ, Plascencia-VillaG, PerryG. Neuroprotective and antioxidant effect of ginkgo biloba extract against AD and other neurological disorders. Neurotherapeutics. 2019;16(3):666–674. doi:10.1007/s13311-019-00767-831376068
   PubMed Web of Science ®Google Scholar
• KangJM, LinS. Ginkgo biloba and its potential role in glaucoma. Curr Opin Ophthalmol. 2018;29(2):116–120. doi:10.1097/ICU.000000000000045929206653
   PubMed Web of Science ®Google Scholar
• ZhengW, XiangYQ, NgCH, UngvariGS, ChiuHF, XiangYT. Extract of Ginkgo biloba for tardive dyskinesia: meta-analysis of randomized controlled trials. Pharmacopsychiatry. 2016;49(3):107–111. doi:10.1055/s-0042-10288426979525
   PubMed Web of Science ®Google Scholar
• MahmoudF, AbulH, OnadekoB, KhadadahM, HainesD, MorganG. In vitro effects of Ginkgolide B on lymphocyte activation in atopic asthma: comparison with cyclosporin A. Jpn J Pharmacol. 2000;83(3):241–245. doi:10.1016/S0021-5198(19)30590-610952073
   PubMedGoogle Scholar
• RuiTQ, ZhangL, QiaoHZ, et al. Preparation and physicochemical and pharmacokinetic characterization of Ginkgo lactone nanosuspensions for antiplatelet aggregation. J Pharm Sci. 2016;105(1):242–249. doi:10.1016/j.xphs.2015.10.00226852855
   PubMed Web of Science ®Google Scholar
• KudoloGB, DorseyS, BlodgettJ. Effect of the ingestion of Ginkgo biloba extract on platelet aggregation and urinary prostanoid excretion in healthy and type 2 diabetic subjects. Thromb Res. 2002;108(2–3):151–160. doi:10.1016/S0049-3848(02)00394-812590952
   PubMed Web of Science ®Google Scholar
• Dutta-RoyAK, GordonMJ, KellyC, et al. Inhibitory effect of Ginkgo biloba extract on human platelet aggregation. Platelets. 1999;10(5):298–305. doi:10.1080/0953710997593316801106
   PubMed Web of Science ®Google Scholar
• KorthR, NunezD, BidaultJ, BenvenisteJ. Comparison of three paf-acether receptor antagonist ginkgolides. Eur J Pharmacol. 1988;152(1–2):101–110. doi:10.1016/0014-2999(88)90840-02850196
   PubMed Web of Science ®Google Scholar
• RyuKH, HanHY, LeeSY, et al. Ginkgo biloba extract enhances antiplatelet and antithrombotic effects of cilostazol without prolongation of bleeding time. Thromb Res. 2009;124(3):328–334. doi:10.1016/j.thromres.2009.02.01019349067
   PubMed Web of Science ®Google Scholar
• ChanAL, LeungHW, WuJW, ChienTW. Risk of hemorrhage associated with co-prescriptions for Ginkgo biloba and antiplatelet or anticoagulant drugs. J Altern Complement Med. 2011;17(6):513–517. doi:10.1089/acm.2010.029521649517
   PubMed Web of Science ®Google Scholar
• KellermannAJ, KloftC. Is there a risk of bleeding associated with standardized Ginkgo biloba extract therapy? A systematic review and meta-analysis. Pharmacotherapy. 2011;31(5):490–502. doi:10.1592/phco.31.5.49021923430
   PubMed Web of Science ®Google Scholar
• GardnerCD, ZehnderJL, RigbyAJ, NicholusJR, FarquharJW. Effect of Ginkgo biloba (EGb 761) and aspirin on platelet aggregation and platelet function analysis among older adults at risk of cardiovascular disease: a randomized clinical trial. Blood Coagul Fibrinolysis. 2007;18(8):787–793. doi:10.1097/MBC.0b013e3282f102b117982321
   PubMed Web of Science ®Google Scholar
• DiamondBJ, ShiflettSC, FeiwelN, et al. Ginkgo biloba extract: mechanisms and clinical indications. Arch Phys Med Rehabil. 2000;81(5):668–678.10807109
   PubMed Web of Science ®Google Scholar
• LiL, ZhaoY, DuF, et al. Intestinal absorption and presystemic elimination of various chemical constituents present in GBE50 extract, a standardized extract of Ginkgo biloba leaves. Curr Drug Metab. 2012;13(5):494–509. doi:10.2174/138920021120905049422292790
   PubMed Web of Science ®Google Scholar
• ClarkJC, KavanaghDM, WatsonS, et al. Adenosine and forskolin inhibit platelet aggregation by collagen but not the proximal signalling events. Thromb Haemost. 2019;119(7):1124–1137. doi:10.1055/s-0039-168878831129912
   PubMed Web of Science ®Google Scholar
• ChenP, ZhangD, LiM, et al. Discovery of novel, potent, isosteviol-based antithrombotic agents. Eur J Med Chem. 2019;183:111722. doi:10.1016/j.ejmech.2019.11172231563807
   PubMed Web of Science ®Google Scholar
• WuQL, DongJ, ZengHW, LvC, LiuAJ, ZhangWD. Monitoring antiplatelet aggregation in vivo and in vitro by microtiter plate method. J Cardiovasc Pharmacol. 2020;75(4):314–320. doi:10.1097/FJC.000000000000080132040035
   PubMed Web of Science ®Google Scholar
• ChanMV, WarnerTD. Standardised optical multichannel (optimul) platelet aggregometry using high-speed shaking and fixed time point readings. Platelets. 2012;23(5):404–408. doi:10.3109/09537104.2011.60306621806495
   PubMed Web of Science ®Google Scholar
• IanevskiA, GiriAK, AittokallioT. SynergyFinder 2.0: visual analytics of multi-drug combination synergies. Nucleic Acids Res. 2020;48(W1):W488–w493. doi:10.1093/nar/gkaa21632246720
   PubMed Web of Science ®Google Scholar
• RuJ, LiP, WangJ, et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform. 2014;6:13. doi:10.1186/1758-2946-6-1324735618
   PubMed Web of Science ®Google Scholar
• XuX, ZhangW, HuangC, et al. A novel chemometric method for the prediction of human oral bioavailability. Int J Mol Sci. 2012;13(6):6964–6982. doi:10.3390/ijms1306696422837674
   PubMed Web of Science ®Google Scholar
• TaoW, XuX, WangX, et al. Network pharmacology-based prediction of the active ingredients and potential targets of Chinese herbal Radix Curcumae formula for application to cardiovascular disease. J Ethnopharmacol. 2013;145(1):1–10. doi:10.1016/j.jep.2012.09.05123142198
   PubMed Web of Science ®Google Scholar
• DainaA, MichielinO, ZoeteV. SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res. 2019;47(W1):W357–w364. doi:10.1093/nar/gkz38231106366
   PubMed Web of Science ®Google Scholar
• WangL, MaC, WipfP, LiuH, SuW, XieXQ. TargetHunter: an in silico target identification tool for predicting therapeutic potential of small organic molecules based on chemogenomic database. AAPS J. 2013;15(2):395–406. doi:10.1208/s12248-012-9449-z23292636
   PubMed Web of Science ®Google Scholar
• WishartDS, FeunangYD, GuoAC, et al. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2018;46(D1):D1074–d1082. doi:10.1093/nar/gkx103729126136
   PubMed Web of Science ®Google Scholar
• WangJH, ZhaoLF, WangHF, et al. GenCLiP 3: mining human genes’ functions and regulatory networks from PubMed based on co-occurrences and natural language processing. Bioinformatics. 2019:1973–1975. doi:10.1093/bioinformatics/btz807
   Web of Science ®Google Scholar
• BardouP, MarietteJ, EscudieF, DjemielC, KloppC. jvenn: an interactive Venn diagram viewer. BMC Bioinform. 2014;15(1):293. doi:10.1186/1471-2105-15-293
   PubMed Web of Science ®Google Scholar
• ShannonP, MarkielA, OzierO, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498–2504. doi:10.1101/gr.123930314597658
   PubMed Web of Science ®Google Scholar
• ZhouY, ZhouB, PacheL, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10(1):1523. doi:10.1038/s41467-019-09234-630944313
   PubMed Web of Science ®Google Scholar
• BindeaG, MlecnikB, HacklH, et al. ClueGO: a cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics. 2009;25(8):1091–1093. doi:10.1093/bioinformatics/btp10119237447
   PubMed Web of Science ®Google Scholar
• LiS, ZhangX, FangQ, et al. Ginkgo biloba extract improved cognitive and neurological functions of acute ischaemic stroke: a randomised controlled trial. Stroke Vasc Neurol. 2017;2(4):189–197. doi:10.1136/svn-2017-00010429507779
   PubMedGoogle Scholar
• KimHS, KimGY, YeoCW, et al. The effect of Ginkgo biloba extracts on the pharmacokinetics and pharmacodynamics of cilostazol and its active metabolites in healthy Korean subjects. Br J Clin Pharmacol. 2014;77(5):821–830. doi:10.1111/bcp.1223624001154
   PubMed Web of Science ®Google Scholar
• HongJM, ShinDH, LimYA, LeeJS, JooIS. Ticlopidine with Ginkgo Biloba extract: a feasible combination for patients with acute cerebral ischemia. Thromb Res. 2013;131(4):e147–153. doi:10.1016/j.thromres.2013.01.02623477707
   PubMed Web of Science ®Google Scholar
• ChenF, LiL, XuF, et al. Systemic and cerebral exposure to and pharmacokinetics of flavonols and terpene lactones after dosing standardized Ginkgo biloba leaf extracts to rats via different routes of administration. Br J Pharmacol. 2013;170(2):440–457. doi:10.1111/bph.1228523808355
   PubMed Web of Science ®Google Scholar
• GkourogianniAV, KiouptsiK, KolokaV, et al. Synergistic effect of peptide inhibitors derived from the extracellular and intracellular domain of α(IIb) subunit of integrin α(IIb)β(3) on platelet activation and aggregation. Platelets. 2018;29(1):34–40. doi:10.1080/09537104.2017.129380428351192
   PubMed Web of Science ®Google Scholar
• BouhtitF, NajarM, Moussa AghaD, et al. New anti-leukemic effect of carvacrol and thymol combination through synergistic induction of different cell death pathways. Molecules. 2021;26(2):2. doi:10.3390/molecules26020410
   Web of Science ®Google Scholar
• SmolenskiA. Novel roles of cAMP/cGMP-dependent signaling in platelets. J Thromb Haemost. 2012;10(2):167–176. doi:10.1111/j.1538-7836.2011.04576.x22136590
   PubMed Web of Science ®Google Scholar
• MurphyPT, GraceS, GlaveyS, QuinnJ. Rivaroxaban may increase platelet activation in vivo via thromboxane A2. Circ Res. 2019;125(2):e9. doi:10.1161/CIRCRESAHA.119.31545331268853
   PubMed Web of Science ®Google Scholar
• ZhaoZ, LiuN, HuangJ, LuPH, XuXM. Inhibition of cPLA2 activation by Ginkgo biloba extract protects spinal cord neurons from glutamate excitotoxicity and oxidative stress-induced cell death. J Neurochem. 2011;116(6):1057–1065. doi:10.1111/j.1471-4159.2010.07160.x21182525
   PubMed Web of Science ®Google Scholar
• OngWY, FarooquiT, KokotosG, FarooquiAA. Synthetic and natural inhibitors of phospholipases A2: their importance for understanding and treatment of neurological disorders. ACS Chem Neurosci. 2015;6(6):814–831. doi:10.1021/acschemneuro.5b0007325891385
   PubMed Web of Science ®Google Scholar
• RasheedH, SaeedSA. Involvement of thromboxane A2 and tyrosine kinase in the synergistic interaction of platelet activating factor and calcium ionophore A23187 in human platelet aggregation. Exp Mol Med. 2004;36(3):220–225. doi:10.1038/emm.2004.3015272233
   PubMed Web of Science ®Google Scholar
• SaeedSA, RasheedH. Calcium-dependent synergistic interaction of platelet activating factor and epinephrine in human platelet aggregation. Acta Pharmacol Sin. 2003;24(1):31–36.12511226
   PubMed Web of Science ®Google Scholar
• KoppE, GhoshS. Inhibition of NF-kappa B by sodium salicylate and aspirin. Science. 1994;265(5174):956–959. doi:10.1126/science.80528548052854
   PubMed Web of Science ®Google Scholar
• HsiaCW, WuMP, ShenMY, HsiaCH, ChungCL, SheuJR. Regulation of human platelet activation and prevention of arterial thrombosis in mice by auraptene through inhibition of NF-kappaB pathway. Int J Mol Sci. 2020;21(13):4810. doi:10.3390/ijms21134810
   Web of Science ®Google Scholar
• SattiHH, KhaleelEF, BadiRM, ElrefaieAO, MostafaDG. Antiplatelet activity of astaxanthin in control- and high cholesterol-fed rats mediated by down-regulation of P2Y12, inhibition of NF-kappaB, and increasing intracellular levels of cAMP. Platelets. 2020;1–10. doi:10.1080/09537104.2020.1756237
   Web of Science ®Google Scholar
• LiuY, ShieldsLBE, GaoZ, et al. Current understanding of platelet-activating factor signaling in central nervous system diseases. Mol Neurobiol. 2017;54(7):5563–5572. doi:10.1007/s12035-016-0062-527613281
   PubMed Web of Science ®Google Scholar
• ChoHJ, NamKS. Inhibitory effect of ginkgolide B on platelet aggregation in a cAMP- and cGMP-dependent manner by activated MMP-9. J Biochem Mol Biol. 2007;40(5):678–683.17927900
   PubMedGoogle Scholar
• LiuX, ZhaoG, YanY, BaoL, ChenB, QiR. Ginkgolide B reduces atherogenesis and vascular inflammation in ApoE(-/-) mice. PLoS One. 2012;7(5):e36237. doi:10.1371/journal.pone.003623722662117
   PubMed Web of Science ®Google Scholar
• LibbyP, RidkerPM, HanssonGK. Leducq Transatlantic Network on A. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol. 2009;54(23):2129–2138. doi:10.1016/j.jacc.2009.09.00919942084
   PubMed Web of Science ®Google Scholar
• Suarez-RiveroJM, Pastor-MaldonadoCJ, Povea-CabelloS, et al. From mitochondria to atherosclerosis: the inflammation path. Biomedicines. 2021;9(3):258. doi:10.3390/biomedicines903025833807807
   PubMed Web of Science ®Google Scholar
• MalekmohammadK, SewellRDE, Rafieian-KopaeiM. Antioxidants and atherosclerosis: mechanistic aspects. Biomolecules. 2019;9(8):301. doi:10.3390/biom9080301
   PubMed Web of Science ®Google Scholar
• SummerhillV, KaragodinV, GrechkoA, MyasoedovaV, OrekhovA. Vasculoprotective role of olive oil compounds via modulation of oxidative stress in atherosclerosis. Front Cardiovasc Med. 2018;5:188. doi:10.3389/fcvm.2018.0018830622950
   PubMed Web of Science ®Google Scholar
• TianJ, LiuY, ChenK. Ginkgo biloba extract in vascular protection: molecular mechanisms and clinical applications. Curr Vasc Pharmacol. 2017;15(6):532–548. doi:10.2174/157016111566617071309554528707602
   PubMed Web of Science ®Google Scholar
• DiamondBJ, BaileyMR. Ginkgo biloba: indications, mechanisms, and safety. Psychiatr Clin North Am. 2013;36(1):73–83. doi:10.1016/j.psc.2012.12.00623538078
   PubMed Web of Science ®Google Scholar